Eisai: MHLW Grants Orphan Drug Designation in Japan to Mecobalamin Ultrahigh-Dose Formulation with Prospective Indication for Delaying the Progression of Disease and Functional Impairment of ALS
TOKYO, May 27, 2022 – (J […]
Cloud Comrade Awarded SAP Recognized Expertise in SAP HANA
Singapore, Dec 14, 2021 – […]
Eisai and Biogen Inc. Announce U.S. FDA Grants Breakthough Therapy Designation for Lecanemab (BAN2401)
TOKYO, Jun 24, 2021 – (J […]
APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
Foster City, CA, Hangzhou, Chi […]